Detalles de la búsqueda
1.
New targeted therapies in liposarcoma: state of art and future perspectives.
Curr Opin Oncol
; 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38726840
2.
Trabectedin use in soft-tissue sarcoma patients in a real-world setting: Data from an Italian national drug-access registry.
Int J Cancer
; 152(4): 761-768, 2023 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36196483
3.
Pathological and radiological response following neoadjuvant treatments in primary localized resectable myxofibrosarcoma and undifferentiated pleomorphic sarcoma of the extremities and trunk wall.
Cancer
; 129(21): 3417-3429, 2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37452607
4.
Weekly cisplatin with or without imatinib in advanced chordoma: A retrospective case-series analysis from the Italian Rare Cancers Network.
Cancer
; 128(7): 1439-1448, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35026050
5.
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2).
Cancer
; 128(10): 1958-1966, 2022 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35201621
6.
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial.
Cancer
; 128(1): 85-93, 2022 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34643947
7.
Refining the Approach to Patients with Primary Soft Tissue Sarcoma of the Extremities and Trunk Wall: Outcome Improvement Over Time at a Single Institution.
Ann Surg Oncol
; 29(5): 3274-3286, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35000087
8.
B Cell Endosomal RAB7 Promotes TRAF6 K63 Polyubiquitination and NF-κB Activation for Antibody Class-Switching.
J Immunol
; 204(5): 1146-1157, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31932498
9.
Expectations, experiences and preferences of patients and physicians in the informed consent process for clinical trials in oncology.
Support Care Cancer
; 30(3): 1911-1921, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34618238
10.
Is rare cancer care organized at national health system level? Multiple case study in six EU countries.
Eur J Public Health
; 32(6): 852-857, 2022 11 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36374643
11.
Ethical issues in oncology practice: a qualitative study of stakeholders' experiences and expectations.
BMC Med Ethics
; 23(1): 67, 2022 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35773683
12.
Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma.
Genomics
; 113(5): 3439-3448, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34339817
13.
Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case-series analysis within the Italian Rare Cancer Network.
Cancer
; 127(4): 569-576, 2021 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33107985
14.
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities.
Cancer
; 127(16): 2934-2942, 2021 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33910263
15.
HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation.
Nat Immunol
; 10(5): 540-50, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19363484
16.
Unplanned Excision of Extremity and Trunk Wall Soft Tissue Sarcoma: To Re-resect or Not to Re-resect?
Ann Surg Oncol
; 28(8): 4706-4717, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33511543
17.
Evaluating the effectiveness of clinical ethics committees: a systematic review.
Med Health Care Philos
; 24(1): 135-151, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33219898
18.
Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 21(3): 456-466, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32066540
19.
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network.
Cancer
; 126(1): 98-104, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31536651
20.
Correction: Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin.
Br J Cancer
; 122(7): 1120, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32047297